Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Haemonetics Stock Quote

Haemonetics (NYSE: HAE)

$84.24
(-0.8%)
-$0.64
Price as of April 16, 2024, 1:47 p.m. ET

Haemonetics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
HAE +0.12% +3.84% +0.76% +1,330%
S&P +22.34% +74.52% +11.78% +1,247%

Haemonetics Company Info

Haemonetics Corp. is a global healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.